Fatemah O. Kamel
- Molecular Biology
- Health top 10%
- Infectious Diseases
- Neurology top 10%
- Physiology
- Co-authors
- Rania MagadmiRosemary J. BoytonRichard ReynoldsPascal F. DurrenbergerMalcolm J. W. SimDaniel M. AltmannRichard NicholasAnna Ettorre
- Topics
- COVID-19 Clinical Research Studies (3 papers)Drug Transport and Resistance Mechanisms (3 papers)Alzheimer's disease research and treatments (3 papers)
- Partner nations
- Saudi ArabiaEgyptUnited States
In The Last Decade
Fatemah O. Kamel
33 papers receiving 619 citations
Peers
Comparison fields: 5 of 114
- Molecular Biology 114
- Health 100
- Infectious Diseases 90
- Neurology 89
- Physiology 68
Countries citing papers authored by Fatemah O. Kamel
This map shows the geographic impact of Fatemah O. Kamel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatemah O. Kamel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatemah O. Kamel more than expected).
Fields of papers citing papers by Fatemah O. Kamel
This network shows the impact of papers produced by Fatemah O. Kamel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatemah O. Kamel. The network helps show where Fatemah O. Kamel may publish in the future.
Co-authorship network of co-authors of Fatemah O. Kamel
This figure shows the co-authorship network connecting the top 25 collaborators of Fatemah O. Kamel. A scholar is included among the top collaborators of Fatemah O. Kamel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatemah O. Kamel. Fatemah O. Kamel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 5 | |
| 10 | 8 | |
| 11 | 6 | |
| 12 | 21 | |
| 13 | 3 | |
| 14 | 39 | |
| 15 | 6 | |
| 16 | 49 | |
| 17 | 36 | |
| 18 | 18 | |
| 19 | 15 | |
| 20 | 246 |
About Fatemah O. Kamel
Fatemah O. Kamel is a scholar working on Applied Microbiology and Biotechnology, Toxicology and Geriatrics and Gerontology, having authored 36 papers that have together received 633 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Alzheimer's disease research and treatments (3 papers). The work is most often cited by research in Biological Psychiatry (30 citations), Health (100 citations) and Drug Discovery (2 citations). Fatemah O. Kamel has collaborated with scholars based in Saudi Arabia, Egypt and United States. Frequent co-authors include Rania Magadmi, Rosemary J. Boyton, Richard Reynolds, Pascal F. Durrenberger, Malcolm J. W. Sim, Daniel M. Altmann, Richard Nicholas, Anna Ettorre, Omar Malik and Sameer Alharthi. Their work appears in journals such as Blood, BMC Public Health and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.